Bacterial infection of paranasal sinuses lasting <4 weeks, typically following viral URI.
Also known as: acute bacterial sinusitis, ABRS, acute rhinosinusitis, sinus infection
Overview
Acute bacterial rhinosinusitis (ABRS) is symptomatic inflammation of the paranasal sinuses lasting <4 weeks, distinguished from viral rhinosinusitis by duration ≥10 days without improvement, worsening after initial improvement ('double-sickening'), or severe onset with high fever and purulent discharge ≥3-4 consecutive days.
Epidemiology
Acute rhinosinusitis affects ~12% of US adults annually. Only 0.5-2% of viral rhinosinusitis cases progress to ABRS, yet antibiotics are over-prescribed. Maxillary sinus most commonly affected, followed by ethmoid, frontal, then sphenoid.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Acute Bacterial Rhinosinusitis (ABRS) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Dental abscess — Maxillary tooth pain with percussion, periapical lucency on dental imaging; treat underlying tooth
Migraine or tension headache — Recurrent headache with photophobia/phonophobia or scalp tension; no purulent discharge or fever
Invasive fungal sinusitis (mucormycosis) — Immunocompromised or poorly controlled diabetic with rapid facial pain, black eschar on turbinate or palate, cranial neuropathies; emergent ENT/surgical debridement + IV amphotericin B
Nasal foreign body — Unilateral purulent foul discharge in a child
Trigeminal neuralgia — Lancinating facial pain triggered by light touch; no purulent discharge
Diagnostic workup
Diagnostic criteria
IDSA 2012 / AAO-HNS 2015 — ABRS if ANY of: (1) symptoms ≥10 days without improvement, (2) severe symptoms — purulent discharge or facial pain with fever ≥39°C (102°F) for ≥3-4 consecutive days at illness onset, or (3) 'double-sickening' — new fever, headache, or increased nasal discharge after a viral URI that had begun improving.
Labs
ABRS is a clinical diagnosis — no routine labs
Consider CBC, blood cultures if complications suspected
Sinus aspirate culture (otolaryngologist) reserved for treatment failure, immunocompromised, or complicated disease
Imaging
Not routinely indicated in uncomplicated ABRS
CT sinus without contrast if complications suspected, treatment failure, recurrent disease, or surgical planning
CT or MRI with contrast for orbital cellulitis, cavernous sinus thrombosis, brain abscess
Plain sinus films and ultrasound have largely been abandoned
Diagnostic algorithm
flowchart TD
A[URI / sinus symptoms] --> B{Symptom duration<br/>and pattern}
B -->|<10 days, improving| C[Viral rhinosinusitis<br/>Supportive care]
B -->|≥10 days no improvement| D[ABRS]
B -->|Severe onset ≥3-4 d<br/>T≥39 + purulent| D
B -->|Double-sickening<br/>worse after improvement| D
D --> E{Adult<br/>uncomplicated?}
E -->|Yes| F[Option:<br/>watchful waiting 7 d<br/>OR amox-clav]
E -->|No / risk factors| G[High-dose amox-clav<br/>5-10 days]
F --> H{Improved?}
G --> H
H -->|Yes| I[Complete course]
H -->|No at 72 h| J[Switch antibiotic<br/>± CT sinus<br/>± ENT referral]
D --> K{Red flags?<br/>Orbital/intracranial/<br/>immunocompromised}
K -->|Yes| L[Urgent CT/MRI<br/>IV antibiotics<br/>ENT/Ophtho]
Diagnosis and management algorithm for acute bacterial rhinosinusitis.
Treatment
First-line
Symptomatic care for ALL: saline nasal irrigation, intranasal corticosteroid (fluticasone, mometasone), analgesics (acetaminophen, NSAIDs), adequate hydration, oral or topical decongestant (pseudoephedrine or oxymetazoline ≤5 days)
Watchful waiting × 7 days for uncomplicated ABRS in adults (AAO-HNS option) if reliable follow-up
First-line antibiotic: amoxicillin-clavulanate 500/125 mg TID or 875/125 mg BID × 5-10 days (adults); 45 mg/kg/day amoxicillin component for children — IDSA recommends amox-clav OVER amoxicillin alone due to rising H. influenzae beta-lactamase rates
High-dose amoxicillin-clavulanate (2 g BID adults; 90 mg/kg/day amoxicillin component children) for: severe infection, immunocompromised, recent antibiotic use, age <2 or >65, daycare, prior hospitalization, region with >10% PCN-resistant S. pneumoniae
Second-line / adjunct
Penicillin allergy (non-anaphylactic): doxycycline (adults), or cefuroxime/cefpodoxime/cefdinir
Severe penicillin allergy: doxycycline OR levofloxacin/moxifloxacin (reserve fluoroquinolones — FDA boxed warnings)
Treatment failure at 72 h: switch to higher-dose amox-clav, doxycycline, or levofloxacin; consider CT and ENT referral
Avoid macrolides (azithromycin, clarithromycin) and TMP-SMX as monotherapy due to high pneumococcal resistance
Refer to ENT for: orbital/intracranial complications, recurrent ABRS (≥4 episodes/year), anatomic abnormality, immunocompromised
Complications
Orbital cellulitis or abscess (especially ethmoid sinusitis in children) — proptosis, ophthalmoplegia, vision loss
Invasive fungal sinusitis in immunocompromised — mucormycosis, aspergillosis
Progression to chronic rhinosinusitis
PANCE pearls
Distinguishing viral from bacterial sinusitis: duration ≥10 days, double-sickening, or severe high-fever onset with purulent discharge ≥3-4 days.
IDSA 2012 recommends amoxicillin-clavulanate over amoxicillin alone — most boards updated to this answer.
Avoid macrolides and TMP-SMX as monotherapy — >25% pneumococcal resistance.
Periorbital swelling + decreased EOM + proptosis = orbital cellulitis → IV antibiotics + CT + ophthalmology/ENT.
Black necrotic eschar on palate or turbinates in a diabetic or immunocompromised patient = mucormycosis — emergent surgical debridement and IV amphotericin B.
Intranasal corticosteroids improve symptoms in ABRS as adjunct therapy.
References
IDSA 2012 — Chow AW et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis. Clin Infect Dis 2012;54(8):e72-e112
AAO-HNS 2015 — Rosenfeld RM et al. Clinical Practice Guideline (Update): Adult Sinusitis. Otolaryngol Head Neck Surg 2015;152(2S):S1-S39
AAP 2013 — Wald ER et al. Clinical Practice Guideline for the Diagnosis and Management of Acute Bacterial Sinusitis in Children Aged 1 to 18 Years. Pediatrics 2013
Practice EENT questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.